PDB Short entry for 2DO4
HEADER    IMMUNE SYSTEM                           27-APR-06   2DO4              
TITLE     SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN OF SQUAMOUS CELL         
TITLE    2 CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 3                            
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T-CELLS 3;   
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: RNA RECOGNITION MOTIF;                                     
COMPND   5 SYNONYM: SART-3, HSART-3, TAT-INTERACTING PROTEIN OF 110 KDA, TIP110;
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: SART3;                                                         
SOURCE   6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   7 EXPRESSION_SYSTEM_PLASMID: P051121-11;                               
SOURCE   8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS                           
KEYWDS    RRM DOMAIM, RDB, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON     
KEYWDS   2 PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL         
KEYWDS   3 GENOMICS/PROTEOMICS INITIATIVE, RSGI, IMMUNE SYSTEM                  
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    W.TANABE,S.SUZUKI,Y.MUTO,M.INOUE,T.KIGAWA,T.TERADA,M.SHIROUZU,        
AUTHOR   2 S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI)    
REVDAT   3   09-MAR-22 2DO4    1       REMARK SEQADV                            
REVDAT   2   24-FEB-09 2DO4    1       VERSN                                    
REVDAT   1   17-APR-07 2DO4    0                                                
JRNL        AUTH   S.SUZUKI,Y.MUTO,M.INOUE,T.KIGAWA,T.TERADA,M.SHIROUZU,        
JRNL        AUTH 2 S.YOKOYAMA                                                   
JRNL        TITL   SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN OF SQUAMOUS     
JRNL        TITL 2 CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 3               
JRNL        REF    TO BE PUBLISHED                                              
JRNL        REFN                                                                
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : XWINNMR 3.5, CYANA 2.0.17                            
REMARK   3   AUTHORS     : BRUKER (XWINNMR), GUNTERT, P. (CYANA)                
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2DO4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAY-06.                  
REMARK 100 THE DEPOSITION ID IS D_1000025642.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 7.0                                
REMARK 210  IONIC STRENGTH                 : 120MM                              
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1.1MM 13C/15N-PROTEIN; 20MM D      
REMARK 210                                   -TRIS-HCL(PH7.0); 100MM NACL;      
REMARK 210                                   1MM D-DTT; 0.02% NAN3; 90% H2O,    
REMARK 210                                   10% D2O                            
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 3D_15N-SEPARATED_NOESY; 3D_13C     
REMARK 210                                   -SEPARATED_NOESY                   
REMARK 210  SPECTROMETER FIELD STRENGTH    : 800 MHZ                            
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NMRPIPE 20031121, NMRVIEW 5.0.4,   
REMARK 210                                   KUJIRA 0.9742, CYANA 2.0.17        
REMARK 210   METHOD USED                   : TORSION ANGLE DYANAMICS,           
REMARK 210                                   SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 100                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : TARGET FUNCTION, STRUCTURES WITH   
REMARK 210                                   THE LOWEST ENERGY, STRUCTURES      
REMARK 210                                   WITH THE LEAST RESTRAINT           
REMARK 210                                   VIOLATIONS                         
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 THR A 796      155.56    -37.74                                   
REMARK 500  1 CYS A 812      142.67    -37.71                                   
REMARK 500  1 GLU A 868       48.18     74.50                                   
REMARK 500  1 SER A 876       83.92    -58.85                                   
REMARK 500  2 GLU A 799       52.17   -100.00                                   
REMARK 500  2 ASP A 862      109.43    -41.58                                   
REMARK 500  2 GLU A 868       46.73     72.30                                   
REMARK 500  2 SER A 876       98.02    -54.47                                   
REMARK 500  3 VAL A 791       40.28   -103.70                                   
REMARK 500  3 SER A 795      -65.48    -90.97                                   
REMARK 500  3 LYS A 800       51.64   -115.14                                   
REMARK 500  3 PHE A 810      -35.68    -37.56                                   
REMARK 500  3 CYS A 812      153.26    -42.26                                   
REMARK 500  3 ASP A 862      117.35    -36.60                                   
REMARK 500  3 SER A 876      140.12    -35.01                                   
REMARK 500  3 SER A 878      120.00    -39.47                                   
REMARK 500  4 CYS A 812      161.76    -44.39                                   
REMARK 500  4 ASP A 862      102.88    -34.95                                   
REMARK 500  4 GLU A 868       47.52     71.52                                   
REMARK 500  4 SER A 876      142.69    -35.23                                   
REMARK 500  5 SER A 786      151.68    -43.58                                   
REMARK 500  5 SER A 797       66.18   -115.00                                   
REMARK 500  5 GLU A 815      -70.82    -41.19                                   
REMARK 500  5 ASP A 862      101.09    -35.70                                   
REMARK 500  5 SER A 876      131.79    -39.19                                   
REMARK 500  6 SER A 788      140.48    -37.49                                   
REMARK 500  6 ARG A 793       74.91   -118.59                                   
REMARK 500  6 GLU A 799       50.39    -99.05                                   
REMARK 500  6 CYS A 812      152.01    -49.70                                   
REMARK 500  6 ALA A 837       33.67    -90.09                                   
REMARK 500  6 ASP A 862      106.64    -35.05                                   
REMARK 500  6 GLU A 868       42.51     70.72                                   
REMARK 500  6 SER A 876      143.43    -35.55                                   
REMARK 500  7 SER A 788      123.23   -170.63                                   
REMARK 500  7 GLU A 799       42.70    -94.58                                   
REMARK 500  7 CYS A 812      155.27    -44.89                                   
REMARK 500  7 ALA A 837       34.54    -93.96                                   
REMARK 500  7 ASP A 862      103.53    -46.53                                   
REMARK 500  7 ASN A 869      112.32   -162.16                                   
REMARK 500  7 ASN A 877       40.97   -109.62                                   
REMARK 500  8 SER A 785       42.09   -101.66                                   
REMARK 500  8 LYS A 802      159.74    -46.25                                   
REMARK 500  8 CYS A 812      159.56    -41.22                                   
REMARK 500  8 ASN A 869      114.55   -161.75                                   
REMARK 500  8 SER A 876      105.15    -56.64                                   
REMARK 500  8 SER A 881      -33.57    -39.34                                   
REMARK 500  9 SER A 786       41.62    -95.53                                   
REMARK 500  9 GLU A 815      -71.77    -49.94                                   
REMARK 500  9 ALA A 837       30.06    -90.36                                   
REMARK 500  9 ASP A 862      108.21    -34.52                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS     125 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
DBREF  2DO4 A  791   877  UNP    Q15020   SART3_HUMAN    791    877             
SEQADV 2DO4 GLY A  784  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  785  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  786  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 GLY A  787  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  788  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  789  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 GLY A  790  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  878  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 GLY A  879  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 PRO A  880  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  881  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 SER A  882  UNP  Q15020              CLONING ARTIFACT               
SEQADV 2DO4 GLY A  883  UNP  Q15020              CLONING ARTIFACT               
SEQRES   1 A  100  GLY SER SER GLY SER SER GLY VAL PHE ARG TYR SER THR          
SEQRES   2 A  100  SER LEU GLU LYS HIS LYS LEU PHE ILE SER GLY LEU PRO          
SEQRES   3 A  100  PHE SER CYS THR LYS GLU GLU LEU GLU GLU ILE CYS LYS          
SEQRES   4 A  100  ALA HIS GLY THR VAL LYS ASP LEU ARG LEU VAL THR ASN          
SEQRES   5 A  100  ARG ALA GLY LYS PRO LYS GLY LEU ALA TYR VAL GLU TYR          
SEQRES   6 A  100  GLU ASN GLU SER GLN ALA SER GLN ALA VAL MET LYS MET          
SEQRES   7 A  100  ASP GLY MET THR ILE LYS GLU ASN ILE ILE LYS VAL ALA          
SEQRES   8 A  100  ILE SER ASN SER GLY PRO SER SER GLY                          
HELIX    1   1 LYS A  814  ALA A  823  1                                  10    
HELIX    2   2 GLU A  851  MET A  861  1                                  11    
SHEET    1   A 5 VAL A 827  LEU A 832  0                                        
SHEET    2   A 5 LEU A 843  TYR A 848 -1  O  TYR A 845   N  ARG A 831           
SHEET    3   A 5 LYS A 802  SER A 806 -1  N  ILE A 805   O  ALA A 844           
SHEET    4   A 5 ILE A 870  ILE A 875 -1  O  ALA A 874   N  PHE A 804           
SHEET    5   A 5 MET A 864  THR A 865 -1  N  MET A 864   O  ILE A 871           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000